Florian E. Buisman

729 total citations
22 papers, 377 citations indexed

About

Florian E. Buisman is a scholar working on Oncology, Hepatology and Surgery. According to data from OpenAlex, Florian E. Buisman has authored 22 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 17 papers in Hepatology and 9 papers in Surgery. Recurrent topics in Florian E. Buisman's work include Hepatocellular Carcinoma Treatment and Prognosis (17 papers), Pancreatic and Hepatic Oncology Research (12 papers) and Colorectal Cancer Treatments and Studies (10 papers). Florian E. Buisman is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (17 papers), Pancreatic and Hepatic Oncology Research (12 papers) and Colorectal Cancer Treatments and Studies (10 papers). Florian E. Buisman collaborates with scholars based in Netherlands, United States and Belgium. Florian E. Buisman's co-authors include Bas Groot Koerkamp, Dirk J. Grünhagen, Cornelis Verhoef, Boris Galjart, T. Peter Kingham, William R. Jarnagin, Vinod P. Balachandran, Eric P. van der Stok, Diederik J. Höppener and Pieter M. H. Nierop and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and European Journal of Cancer.

In The Last Decade

Florian E. Buisman

20 papers receiving 376 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Florian E. Buisman Netherlands 13 259 216 143 107 71 22 377
C. Verhoef Netherlands 8 245 0.9× 122 0.6× 134 0.9× 85 0.8× 30 0.4× 13 349
Jin Yao Teo Singapore 12 159 0.6× 276 1.3× 204 1.4× 115 1.1× 29 0.4× 34 433
Wendy Langeberg United States 2 354 1.4× 318 1.5× 172 1.2× 114 1.1× 69 1.0× 3 496
Seigo Yukisawa Japan 12 165 0.6× 65 0.3× 152 1.1× 182 1.7× 105 1.5× 27 353
Julie N. Leal United States 9 287 1.1× 276 1.3× 214 1.5× 102 1.0× 37 0.5× 14 424
Yizhen Fu China 13 112 0.4× 227 1.1× 100 0.7× 78 0.7× 19 0.3× 38 384
Isabelle Deshaies United States 7 152 0.6× 117 0.5× 121 0.8× 128 1.2× 32 0.5× 12 311
Andrea Fontana Italy 11 136 0.5× 130 0.6× 180 1.3× 137 1.3× 19 0.3× 25 322
Ihl Bohng Choi South Korea 5 68 0.3× 179 0.8× 79 0.6× 86 0.8× 62 0.9× 8 327
G. Plant United Kingdom 6 349 1.3× 437 2.0× 293 2.0× 117 1.1× 53 0.7× 13 576

Countries citing papers authored by Florian E. Buisman

Since Specialization
Citations

This map shows the geographic impact of Florian E. Buisman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florian E. Buisman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florian E. Buisman more than expected).

Fields of papers citing papers by Florian E. Buisman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Florian E. Buisman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florian E. Buisman. The network helps show where Florian E. Buisman may publish in the future.

Co-authorship network of co-authors of Florian E. Buisman

This figure shows the co-authorship network connecting the top 25 collaborators of Florian E. Buisman. A scholar is included among the top collaborators of Florian E. Buisman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Florian E. Buisman. Florian E. Buisman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Buisman, Florian E., Rutger‐Jan Swijnenburg, Bianca Mostert, et al.. (2025). Hepatic Arterial Infusion Pump Chemotherapy in Patients With Unresectable Intrahepatic Cholangiocarcinoma—PUMP-2 Trial. Journal of Clinical Oncology. 44(6). 455–465.
2.
IJzerman, Nikki S., Peter de Bruijn, Florian E. Buisman, et al.. (2023). Systemic exposure of floxuridine after hepatic arterial infusion pump chemotherapy with floxuridine in patients with resected colorectal liver metastases. Biomedicine & Pharmacotherapy. 162. 114625–114625. 3 indexed citations
3.
Buisman, Florian E., Robert R.J. Coebergh van den Braak, Boris Galjart, et al.. (2023). The Effect of Histopathological Growth Patterns of Colorectal Liver Metastases on the Survival Benefit of Adjuvant Hepatic Arterial Infusion Pump Chemotherapy. Annals of Surgical Oncology. 30(13). 7996–8005. 2 indexed citations
4.
Ecker, Brett L., Lily V. Saadat, Thomas Aparicio, et al.. (2022). Recurrence-free survival versus overall survival as a primary endpoint for studies of resected colorectal liver metastasis: a retrospective study and meta-analysis. The Lancet Oncology. 23(10). 1332–1342. 30 indexed citations
5.
Buisman, Florian E., Daniele Giardiello, Nancy E. Kemeny, et al.. (2022). Predicting 10-year survival after resection of colorectal liver metastases; an international study including biomarkers and perioperative treatment. European Journal of Cancer. 168. 25–33. 33 indexed citations
6.
Höppener, Diederik J., Boris Galjart, Pieter M. H. Nierop, et al.. (2021). Histopathological Growth Patterns and Survival After Resection of Colorectal Liver Metastasis: An External Validation Study. JNCI Cancer Spectrum. 5(3). 32 indexed citations
7.
Starmans, Martijn P. A., Florian E. Buisman, François E.J.A. Willemssen, et al.. (2021). Distinguishing pure histopathological growth patterns of colorectal liver metastases on CT using deep learning and radiomics: a pilot study. Clinical & Experimental Metastasis. 38(5). 483–494. 24 indexed citations
8.
Buisman, Florian E., Boris Galjart, Dirk J. Grünhagen, et al.. (2021). Adjuvant intra-arterial chemotherapy for patients with resected colorectal liver metastases: a systematic review and meta-analysis. HPB. 24(3). 299–308. 18 indexed citations
9.
Buisman, Florian E., Nancy E. Kemeny, Raja R. Narayan, et al.. (2020). Recurrence After Liver Resection of Colorectal Liver Metastases: Repeat Resection or Ablation Followed by Hepatic Arterial Infusion Pump Chemotherapy. Annals of Surgical Oncology. 28(2). 808–816. 11 indexed citations
10.
Buisman, Florian E., Eric P. van der Stok, Boris Galjart, et al.. (2020). Histopathological growth patterns as biomarker for adjuvant systemic chemotherapy in patients with resected colorectal liver metastases. Clinical & Experimental Metastasis. 37(5). 593–605. 26 indexed citations
11.
Narayan, Raja R., Thomas Boerner, Florian E. Buisman, et al.. (2020). Addition of adjuvant hepatic artery infusion to systemic chemotherapy following resection of colorectal liver metastases is associated with reduced liver‐related mortality. Journal of Surgical Oncology. 121(8). 1314–1319. 7 indexed citations
12.
Narayan, Raja R., Thomas Boerner, Florian E. Buisman, et al.. (2020). Extrahepatic recurrence rates in patients receiving adjuvant hepatic artery infusion and systemic chemotherapy after complete resection of colorectal liver metastases. Journal of Surgical Oncology. 122(8). 1536–1542.
13.
Buisman, Florian E., Boris Galjart, Eric P. van der Stok, et al.. (2019). The impact of hepatic arterial infusion pump chemotherapy on hepatic recurrences and survival in patients with resected colorectal liver metastases. HPB. 22(9). 1271–1279. 9 indexed citations
14.
Nierop, Pieter M. H., Diederik J. Höppener, Eric P. van der Stok, et al.. (2019). Histopathological growth patterns and positive margins after resection of colorectal liver metastases. HPB. 22(6). 911–919. 21 indexed citations
15.
Buisman, Florian E., Boris Galjart, Eric P. van der Stok, et al.. (2019). Recurrence Patterns After Resection of Colorectal Liver Metastasis are Modified by Perioperative Systemic Chemotherapy. World Journal of Surgery. 44(3). 876–886. 18 indexed citations
16.
Buisman, Florian E., Boris Galjart, Stefan Buettner, et al.. (2019). Primary tumor location and the prognosis of patients after local treatment of colorectal liver metastases: a systematic review and meta-analysis. HPB. 22(3). 351–357. 14 indexed citations
17.
Buisman, Florian E., Boris Galjart, Peter Vermeulen, et al.. (2019). Histopathological growth patterns as a guide for adjuvant systemic chemotherapy in patients with resected colorectal liver metastases. European Journal of Surgical Oncology. 45(2). e10–e10. 2 indexed citations
18.
Buettner, Stefan, Bas Groot Koerkamp, Aslam Ejaz, et al.. (2017). The effect of preoperative chemotherapy treatment in surgically treated intrahepatic cholangiocarcinoma patients—A multi‐institutional analysis. Journal of Surgical Oncology. 115(3). 312–318. 44 indexed citations
19.
Iordens, G.I.T., Florian E. Buisman, Niels W. L. Schep, et al.. (2016). The reliability and reproducibility of the Hertel classification for comminuted proximal humeral fractures compared with the Neer classification. Journal of Orthopaedic Science. 21(5). 596–602. 23 indexed citations
20.
Buisman, Florian E., et al.. (2016). Non-primary breast malignancies: a single institution’s experience of a diagnostic challenge with important therapeutic consequences—a retrospective study. World Journal of Surgical Oncology. 14(1). 166–166. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026